Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 736 posts found.

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 26, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aduro Biotech, Cancer, GSK, ICR, J&J, JJ, Novartis, Sandoz, pharma

The Institute for Cancer Research (ICR) called for new measures to increase the speed with which patients in the UK …

News
mosquito-1016254_1280

Innovative malaria vaccine to be trialled in Malawi

April 23, 2019
Manufacturing and Production GSK, Mosquirix, RTS S, ghana, kenya, malaria, malawi

An innovative malaria vaccine is set to be trialled in Malawi as part of large scale trials which will see …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 18, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Genentech, Gilead, HIV, MS, Novartis, kidney disease, pharma

This week was a good one for clinical trials and a bad one for employees after both Gilead and GSK …

News
gsk_ulverston_plant_impression

GSK to make redundancies at plant in Stevenage

April 17, 2019
Research and Development GSK, GlaxoSmithKline, R&D, redundancies, stevenage

GlaxoSmithKline are set to make redundancies at their site in Stevenage. The move comes as the firm takes “a new …

News

ViiV Healthcares scores first twin-drug FDA approval for untreated HIV-1

April 9, 2019
Manufacturing and Production, Research and Development GSK, HIV, ViiV Healthcare, pharma

ViiV Healthcare, the pharmaceutical firm owned by Shionogi, Pfizer and predominantly GSK, has announced its two-drug HIV regimen Dovato (dolutegravir …

News

Working Life: Dr Paul-Peter Tak, ex-Senior Vice President, Development Lead and Chief Immunology Officer at GSK, Venture Partner at Flagship Pioneering

March 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Working Life, feature

Dr Paul-Peter Tak, ex-Senior Vice President, Development Lead and Chief Immunology Officer at GSK, Venture Partner at Flagship Pioneering.How did …

Feature

Breathing life into COPD research

March 21, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COPD, GSK, feature

Alison Hollands, Vice President, Respiratory, UK Pharmaceuticals at GlaxoSmithKline, addresses the importance of implementing the latest approaches to treating COPD …

Feature

Monthly injections offer similar efficacy to daily pills in HIV phase 3 trials

March 8, 2019
Medical Communications ATLAS, GSK, HIV, ViiV, flair, injectable

A long acting, injectable two drug regimen developed by Pfizer and GSK joint venture ViiV Healthcare and J&J subsidiary Jannsen, …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

February 8, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, Merck, Pfizer, falsified medicines, strike, top 10

The strike in Ireland featured twice in this week’s top 10 after Pfizer employees in County Cork lost a dispute …

News
mr058666-web

GSK buys Merck KGaA’s cancer immunotherapy for $4.2 billion

February 6, 2019
Research and Development GSK, M7824, Merck, immunotherapy

British multinational GlaxoSmithKline has agreed to pay up to €3.7 billion ($4.2 billion) for the rights to Merck KGaA’s next …

News

Philip Hampton to step down from chairman role at GSK

January 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, UK, appointment, pharma

Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …

Appointment
gsk_rd_harlow

GSK acquires oncology firm Tesaro for $5.1 billion

January 23, 2019
Research and Development Cancer, GSK, Tesaro, oncology, ovarian cancer

British multinational GlaxoSmithKline (GSK) have acquired US oncology firm Tesaro for $5.1 billion (£4 billion). Tesaro, a Massachusetts-based clinical stage …

News

Philip Hampton to step down from chairman role at GSK

January 21, 2019
Sales and Marketing Chairman, GSK, GlaxoSmithKline, appointment, philip hampton

Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …

News
gsk_china_8

GSK and Pfizer combine healthcare units in multibillion dollar deal

December 19, 2018
Research and Development GSK, OTC, Pfizer, healthcare, merger

American multinational Pfizer and British firm GlaxoSmithKline are set to combine their consumer healthcare units in a venture worth billions. …

News
pharmafocus_dec_2018_cover

The December issue of Pharmafocus is available to read online now!

December 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eisai, GSK, Gilead, Mundipharma, Pharmafocus, mesothelioma, pharma

The December edition of Pharmafocus is live and available to read online now!Brexit continues to dominate the headlines inside and …

News

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023